MRK vs PRGO · P/E 33, rev $16.61B vs rev $1.99B
Merck & Company Inc (MRK) versus Perrigo Company PLC (PRGO) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Perrigo Company PLC (PRGO) is a drug manufacturers - specialty & generic company listed on US.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported PRGO revenue for 2026-06-27 was $1.99B. Net income was -$324.1M. PRGO currently screens at market cap $1.48B.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. PRGO currently screens at market cap $1.48B.
Not investment advice. Open the MRK and PRGO stock pages for the full models.
Not investment advice.